Diagnoses can be reviewed to ensure they are consistent with the medication being used. This is critical as the new CMS initiative does not penalize facilities for use of antipsychotic medications if the resident presents with Schizophrenia, Bipolar Disorder, Huntington’s Disease, Tourette’s Syndrome or active psychosis.